Register to chat with like-minded investors on our interactive forums.

Get Started

NBSE NeuBase Therapeutics Inc

0.378

0.00 (0.00%)

Sep 19 2024 - Closed

Delayed by 15 minutes

NeuBase Therapeutics names Phathom's Todd Branning as new CFO

To read the full story on Seeking Alpha, click here.

NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more NeuBase Therapeutics Charts.

NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more NeuBase Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

NeuBase Therapeutics Inc News

More NeuBase Therapeutics Inc News Articles

Lightwave Logic

Rennova Health (CE)

Voip Pal Com (QB)

Bioelectronics (PK)

Northwest Biotherapeutics (QB)

Asia Broadband (PK)

Anavex Life Sciences

Fannie Mae (QB)

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Intergrated Cannabis Sol... (PK)

Sincerity Applied Materi... (PK)

Delayed Upgrade Clock